| Others |
■Management of website
JPR (Japanese Patent Practice & Firm Ranking)
Chizainews.com
Iyakunews.com
■Blog
BIOPATENTBLOG
■Research Papers
"Analysis & Discussion of Filing/Examination Trends of Sequence-limited & Non- Sequense-limited Patents in the Field of Antibody Drug Patents", Intellectual Property Management, Vol.65, No.11, 2015, p1582-1592.
"Description Requirements for iPS Cell Production Method Patents - Examination tendencies, response to office actions -", Intellectual Property Management, Vol.66, No.6, 2016, p650-658.
"Important points for patent practice regarding oligonucleotide therapeutics", Practical application & development strategy of advanced treatment technology, section 1-11, April 2017, Technical Information Institute CO., Ltd.
■Serialization in a magazine
"＜Actual Practice＞ Method for pharmaceutical patent search.", PHARM TECH JAPAN, Jiho Inc., July 2018 - July 2019.
■Oral presentation in seminar
"Method for investigation of patent literature & non-patent literature in the field of pharmaceuticals, for the launch of generic drugs & biosimilars.", January 31, 2014.
"Important points for preparing a patent specification/claims & a response to an office action in the field of biotechnology-based pharmaceuticals. - Mainly concerned with antibody drugs -", February 25, 2015.
"Important points & case study of pharmaceutical patent search for patent researcher of br&-name pharmaceutical company. - Mainly concerned with biotechnology drugs -", February 22, 2016, The Pharmaceutical Manufacturers' Association of Tokyo.
"Trends & analysis of biopharmaceutical patent applications, lawsuits, invalidation trials & oppositions.", June 29, 2017, BioPharma Expo 2017.
"Method for biopharmaceutical patent search & its application to invalidation trials & oppositions.", September 13, 2017.
"Trends & analysis of biopharmaceutical patent applications, lawsuits, invalidation trials & oppositions.", July 4, 2019, BioPharma Expo 2019.
"Introduction of recent biopharmaceutical patent applications, lawsuits, invalidation trials & oppositions, and Consideration of the good and bad points of the parties' arguments and what else the losing side could have argued (grounds for invalidation, etc.) - Related to the fields of antibody drugs, nucleic acid drugs, iPS cells, etc. -", February 28, 2020, The Pharmaceutical Manufacturers' Association of Tokyo (Intellectual property study group, patent section). |
